CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

10 hedge funds and large institutions have $25.4M invested in Celyad Oncology SA American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
RIM
1
RS Investment Management
California
$12.7M +$2.77M +66,228 +28%
HM
2
HealthCor Management
New York
$3.65M +$928K +22,181 +34%
PA
3
Perceptive Advisors
New York
$3.14M
CAM
4
Cormorant Asset Management
Massachusetts
$3.14M
DCM
5
DAFNA Capital Management
California
$1.26M
Bank of America
6
Bank of America
North Carolina
$832K +$832K +19,888 New
Zurich Cantonal Bank
7
Zurich Cantonal Bank
Switzerland
$429K +$429K +10,252 New
Morgan Stanley
8
Morgan Stanley
New York
$140K +$119K +2,847 +569%
UBS Group
9
UBS Group
Switzerland
$112K -$4.27M -102,409 -97%
TRCT
10
Tower Research Capital (TRC)
New York
$3K -$34.9K -721 -92%
Millennium Management
11
Millennium Management
New York
-$4.26M -81,942 Closed
FCM
12
Farallon Capital Management
California
-$1.56M -30,000 Closed
AH
13
Achievement Holdings
Illinois
-$1.09K -21,000 Closed
UOC
14
UBS O'Connor
Illinois
-$780K -15,000 Closed
FMA
15
FNY Managed Accounts
New York
-$286K -5,500 Closed